Beiersdorf S&E
This article was originally published in The Rose Sheet
Executive Summary
"Extensive" investments in its North American consumer business drove organic sales in the segment up 22.3% in the first quarter, the Hamburg, Germany company announces May 6. The performance helped fuel a 4% increase in global consumer division sales to €1.32 bil. ($1.68 bil.). Strong sales in China, Russia and Brazil will continue to fuel gains in firm's consumer business, which is expected to outperform the market in 2010, Beiersdorf says. Net sales in the first quarter grew 6.9% at current exchange rates to €1.54 bil. ($1.94 bil.). The firm's after-tax profit rose 22% to €122 mil. ($156 mil.). Commenting on the performance, CEO Thomas-B. Quaas says "our development has yet to quite match our ambitious growth expectations, but we are on the right track.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.